Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03823313 · ClinicalTrials.gov registry record · NA

Feasibility, Acceptability and Preliminary Effects of the Spiritual Care Assessment and Intervention

A NA study of Advanced Cancer and Metastatic Cancer, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
42
Enrollment target
1
Study location

NCT03823313: Completed NA study of Advanced Cancer and Metastatic Cancer, sponsored by Indiana University.

NCT03823313 is a NA study of Advanced Cancer and Metastatic Cancer that has completed, run by Indiana University. The registered enrollment target is 42 participants, below the 246-participant average among 122 other Advanced Cancer trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03823313, a NA study of Advanced Cancer and Metastatic Cancer, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test a spiritual care intervention for adults with advanced cancer and their caregivers. This intervention will assess 4 areas of spiritual experience: meaning and purpose, relationships, transcendence and peace, self-worth and identity. Participants will be asked to complete questionnaires and participate in 4 sessions with research chaplains.

Primary Outcome

number of eligible patients that are consented and enrolled in the trial

Interventions

  • BEHAVIORAL SCAI (Spiritual Care Assessment and Intervention)

Study Locations (1)

Indiana

  • Indiana University Melvin & Bren Simon Cancer Center - Indianapolis

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2018-12-10
Est. Completion 2019-08-28
Phase NA
Indiana University

890 total trials

What the finished NCT03823313 record still lists

NCT03823313 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 246-participant average among 122 other Advanced Cancer trials with a reported enrollment target (83% lower).

The record links to 2 conditions, with Advanced Cancer appearing as the primary indexed condition, and to 1 intervention - of which SCAI (Spiritual Care Assessment and Intervention) is the first listed.

NCT03823313 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT03823313 about?

NCT03823313 is a clinical study titled "Feasibility, Acceptability and Preliminary Effects of the Spiritual Care Assessment and Intervention". The purpose of this study is to test a spiritual care intervention for adults with advanced cancer and their caregivers. This intervention will assess 4 areas of spiritual experience: meaning and purpose, relationships, transcendence and peace, self-worth and identity. Participants will be asked to ...

What is the current status of trial NCT03823313?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2018-12-10. Estimated completion is 2019-08-28.

What conditions does trial NCT03823313 study?

This clinical trial studies the following conditions: Advanced Cancer, Metastatic Cancer.

What interventions are being tested in trial NCT03823313?

The interventions under investigation include: SCAI (Spiritual Care Assessment and Intervention) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03823313?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03823313 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Advanced Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03823313's enrollment target sits among peer trials

42 87th of 122 higher than 35 of 122 other Advanced Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Advanced Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02852213 · 42 participants · Phase 1

    A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

  • NCT03136146 · 42 participants · Phase 2

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

  • NCT03178149 · 42 participants · Phase 1

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • NCT03663530 · 42 participants · NA

    Circadian Misalignment and Energy Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03823313, the US trial registry maintained by the National Library of Medicine. NCT03823313 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.